SCHEMBL2437265

SCHEMBL2437265

N[C@@H]1CN[C@H](CO)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8135885 1.00
SCHEMBL6802772 0.77
SCHEMBL6802769 0.77
SCHEMBL16384332 0.77
SCHEMBL13807257 0.75
SCHEMBL15374982 0.75
SCHEMBL15373068 0.75
SCHEMBL15601423 0.75
SCHEMBL15601155 0.75
SCHEMBL22469364 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237538-A1 TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES SUMMIT CORPORATION PLC (GB) 2011-09-29 US disclosed
US-20090118353-A1 Medicinal composition KITAJIMA AKIHIKO 2009-05-07 US disclosed
US-7485665-B2 Medicinal composition NAGASE CHEMTEX CORPORATION (JP) 2009-02-03 US disclosed
US-20050239861-A1 Medicinal composition NAGASE CHEMTEX CORPORATION (JP) 2005-10-27 US disclosed
EP-1547593-A1 MEDICINAL COMPOSITION Nagase Chemtex Corporation (JP) 2005-06-29 EP disclosed